Filter Results
:
(2,143)
Show Results For
-
All HBS Web
(4,545)
- People (16)
- News (1,465)
- Research (2,143)
- Events (3)
- Multimedia (130)
- Faculty Publications (1,503)
Show Results For
-
All HBS Web
(4,545)
- People (16)
- News (1,465)
- Research (2,143)
- Events (3)
- Multimedia (130)
- Faculty Publications (1,503)
Sort by
- August 21, 2018
- Article
Patient–Physician Gender Concordance and Increased Mortality Among Female Heart Attack Patients
By: Brad Greenwood, Seth Carnahan and Laura Huang
We examine patient gender disparities in survival rates following acute myocardial infarctions (i.e., heart attacks) based on the gender of the treating physician. Using a census of heart attack patients admitted to Florida hospitals between 1991 and 2010, we find...
View Details
Greenwood, Brad, Seth Carnahan, and Laura Huang. "Patient–Physician Gender Concordance and Increased Mortality Among Female Heart Attack Patients." Proceedings of the National Academy of Sciences 115, no. 34 (August 21, 2018).
- February 2016 (Revised March 2022)
- Case
Express Scripts: Promoting Prescription Drug Home Delivery (B)
By: John Beshears, Patrick Rooney and Jenny Sanford
The pharmacy benefit manager (PBM) sector processes prescription drug claims on behalf of companies that offer a prescription drug benefit to their employees. This case follows Bob Nease, Chief Scientist at Express Scripts, as he considers methods to promote home...
View Details
Keywords:
Pharmaceuticals;
Prescription Drugs;
Pharmacy Benefit Manager;
PBM;
Healthcare;
Behavioral Economics;
Choice Architecture;
Active Choice;
Health Care and Treatment;
Service Delivery;
Decision Choices and Conditions;
Order Taking and Fulfillment;
Compensation and Benefits
Beshears, John, Patrick Rooney, and Jenny Sanford. "Express Scripts: Promoting Prescription Drug Home Delivery (B)." Harvard Business School Case 916-040, February 2016. (Revised March 2022.)
- 06 Jul 2009
- Research & Ideas
Conducting Layoffs: ’Necessary Evils’ at Work
key components for taking care of yourself after performing a necessary evil.” It is important to note, however, that we did not gather data about outcomes in this study, so we cannot conclude that any...
View Details
Keywords:
by Martha Lagace
- 03 Apr 2012
- First Look
First Look: April 3
leadership development programs for residents. The authors first present a definition of clinical leadership and highlight evidence that effective frontline clinical leadership improves both clinical outcomes and satisfaction for patients...
View Details
Keywords:
Carmen Nobel
- 03 Feb 2009
- First Look
First Look: February 3, 2009
requires careful dosing, consideration of harmful side effects, and close supervision. We offer a warning label to accompany the practice of setting goals. Download the paper:...
View Details
Keywords:
Martha Lagace
- 2018
- Chapter
The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century
By: Nicholas Bagley, Benjamin Berger, Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern
On the 35th anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades. The most prominent example is the fact that the profit-maximizing price of new...
View Details
Keywords:
Health Care and Treatment;
Laws and Statutes;
Research and Development;
Investment;
Markets;
Monopoly
Bagley, Nicholas, Benjamin Berger, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern. "The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century." Chap. 4 in Innovation Policy and the Economy, Volume 19, edited by Josh Lerner and Scott Stern, 97–137. University of Chicago Press, 2018.
- 15 Dec 2015
- First Look
December 15, 2015
Nikhil G. Thaker Abstract—The goal of a health care system should be to deliver the most value to patients: the outcomes achieved for treating a medical condition relative to...
View Details
Keywords:
Carmen Nobel
- 18 Dec 2018
- First Look
New Research and Ideas, December 18, 2018
the tied product is of worse quality than competitors. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=55176 Find and Replace: R&D Investment Following the Erosion View Details
Keywords:
Dina Gerdeman
- 25 Sep 2017
- Research & Ideas
Why Politics is Failing America, and What Business Can Do To Help
has been a major obstacle to moving the country forward on nearly every front that makes a healthy business environment, from tax reform and restoring economic growth to improving public education and health View Details
Keywords:
by Christina Pazzanese, Harvard Gazette
- November 1978 (Revised October 1989)
- Case
Amicon Corp. (A)
Amicon holds a patent on a new process for the separation of blood plasma from whole blood. It has to decide whether to pursue a direct entry, joint venture, or licensing strategy. If it chooses licensing, there are many sub-issues to consider.
View Details
Capon, Noel. "Amicon Corp. (A)." Harvard Business School Case 579-093, November 1978. (Revised October 1989.)
- 01 Oct 2008
- Research & Ideas
How Much Time Should CEOs Devote to Customers?
business and the company's strategy. In a service business like Tesco's, the health of the brand depends heavily on the quality of the millions...
View Details
Keywords:
by John Quelch
- October 2009 (Revised July 2013)
- Case
Gilead Sciences, Inc.: Access Program
By: V. Kasturi Rangan and Katharine Lee
Gilead Sciences, the U.S. leader in HIV/AIDS medicines, with global sales of $5.4 billion in 2009, had undertaken several innovative actions to make its anti-viral products available to over 100 low- and middle-income countries. Having reached nearly 680,000 patients...
View Details
Keywords:
Health Care and Treatment;
Emerging Markets;
Product;
Sales;
Competitive Strategy;
Biotechnology Industry;
Pharmaceutical Industry
Rangan, V. Kasturi, and Katharine Lee. "Gilead Sciences, Inc.: Access Program." Harvard Business School Case 510-029, October 2009. (Revised July 2013.)
- 01 Sep 2015
- First Look
First Look -- September 1, 2015
these modalities. An incomplete understanding of the value of costly, yet effective, technologies could impede medical innovation and decrease the quality View Details
Keywords:
Sean Silverthorne
- 2012
- Working Paper
The Need for (long) Chains in Kidney Exchange
By: Itai Ashlagi, David Gamarnik, Michael A. Rees and Alvin E. Roth
It has been previously shown that for sufficiently large pools of patient-donor pairs, (almost) efficient kidney exchange can be achieved by using at most 3-way cycles, i.e., by using cycles among no more than 3 patient-donor pairs. However, as kidney exchange has...
View Details
Keywords:
Networks;
Complexity;
Performance Efficiency;
Medical Specialties;
Health Care and Treatment;
Philanthropy and Charitable Giving
Ashlagi, Itai, David Gamarnik, Michael A. Rees, and Alvin E. Roth. "The Need for (long) Chains in Kidney Exchange." NBER Working Paper Series, No. 18202, July 2012.
- 10 Nov 2003
- Research & Ideas
The Hard Numbers on Social Investments
to social problems through market solutions, the rate of return on these deals should be at least as high as traditional early stage investments. The big winners were in the technology and health View Details
Keywords:
by Manda Salls
- 06 Dec 2016
- First Look
December 6, 2016
value-based reimbursement models, however, such as bundled payments, accountable care organizations, and shared savings plans, provide powerful incentives for physicians to regain control over the quantity and View Details
Keywords:
Sean Silverthorne
- 12 Nov 2008
- First Look
First Look: November 12, 2008
selective annexation using a specific policy rule, I find that areas which experienced direct rule have significantly lower levels of access to schools, health centers, and roads in the post-colonial period....
View Details
Keywords:
Martha Lagace
- 10 Apr 2018
- First Look
First Look at New Research, April 10, 2018
about the causes of regional variations in health care expenditures. Using vignettes from patient and physician surveys linked to fee-for-service Medicare expenditures, this...
View Details
Keywords:
Sean Silverthorne
- 04 Apr 2017
- First Look
First Look at New Research, April 4
healthcare providers with revenue cycle management and population health management; the case provides an overview of both sectors. Conifer has been growing rapidly, leading some to question what the best...
View Details
Keywords:
Sean Silverthorne
- 16 Feb 2016
- First Look
February 16, 2016
https://cb.hbsp.harvard.edu/cbmp/product/516027-PDF-ENG Harvard Business School Case 816-060 athenahealth's More Disruption Please Program No abstract available. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/816060-PDF-ENG Harvard Business School Case...
View Details
Keywords:
Sean Silverthorne